Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
Cancer is becoming an increasingly common disease in which abnormal cells aggressively grow, invade, and metastasize. In this paper, we review the biological functions of PEDF (pigmented epithelium-derived factor) against cancer, with a focus on a particular type of bone cancer called osteosarcoma....
| Main Authors: | Chandolu, V., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
Hindawi Publishing Corporation
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/21074 |
Similar Items
The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012)
by: Elahy, Mina, et al.
Published: (2012)
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)
by: Broadhead, M., et al.
Published: (2012)
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)
by: Carnagarin, R., et al.
Published: (2015)
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)
by: Choong, P., et al.
Published: (2011)
The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)
by: Alcantara, M., et al.
Published: (2013)
Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)
by: Carnagarin, Revathy, et al.
Published: (2015)
Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)
by: Chandolu, V., et al.
Published: (2013)
Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)
by: Lee, P., et al.
Published: (2016)
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)
by: Xiao, S., et al.
Published: (2015)
Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
by: Elahy, M., et al.
Published: (2014)
by: Elahy, M., et al.
Published: (2014)
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)
by: Akiyama, T., et al.
Published: (2010)
Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)
by: Carnagarin, R., et al.
Published: (2018)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)
by: Ouyang, Z., et al.
Published: (2018)
Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)
by: Alcantara, M., et al.
Published: (2014)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)
by: Selvarajah, Gayathri Thevi
Published: (2011)
Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)
by: Dass, Crispin
Published: (2008)
The development experience of Malaysia : Lessons for Africa in general and Nigeria in particular
by: Ajibewa, Aderemi Isola
Published: (1997)
by: Ajibewa, Aderemi Isola
Published: (1997)
A proteomic investigation into mechanisms underpinning corticosteroid effects on neural stem cells
by: Al-Mayyahi, Rawaa S., et al.
Published: (2018)
by: Al-Mayyahi, Rawaa S., et al.
Published: (2018)
In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
How naive realism can explain both the particularity and the generality of experience
by: French, Craig, et al.
Published: (2019)
by: French, Craig, et al.
Published: (2019)
Combining classical and molecular approaches elaborates on the complexity of mechanisms underpinning anterior regeneration
by: Evans, Deborah J., et al.
Published: (2011)
by: Evans, Deborah J., et al.
Published: (2011)
Mobile learning: Theoretical underpinnings
by: Imtinan, Umera, et al.
Published: (2012)
by: Imtinan, Umera, et al.
Published: (2012)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Antiproliferative Effects Of The Orthosiphon Stamineus And Tualang Honey On Oral Squamous Cell Carcinoma And Human Osteosarcoma Cell Lines
by: Al-Ghashm, Abdulmlik
Published: (2010)
by: Al-Ghashm, Abdulmlik
Published: (2010)
Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)
by: Indumathy, S., et al.
Published: (2013)
p53-targeted cancer pharmacotherapy: move towards small molecule compounds
by: Kim, S., et al.
Published: (2011)
by: Kim, S., et al.
Published: (2011)
Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
by: Ko, S., et al.
Published: (2014)
by: Ko, S., et al.
Published: (2014)
Autophagy and cancer: taking the ‘toxic’ out of cytotoxics
by: Giuliani, C., et al.
Published: (2013)
by: Giuliani, C., et al.
Published: (2013)
Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse islets
by: Chen, Y., et al.
Published: (2016)
by: Chen, Y., et al.
Published: (2016)
Both reversible self-association and structural changes underpin molecular viscoelasticity of mAb solutions
by: Sarangapani, Prasad S., et al.
Published: (2016)
by: Sarangapani, Prasad S., et al.
Published: (2016)
Similar Items
-
The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012) -
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012) -
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011) -
PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015) -
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)